Table of Content

1 Trastuzumab Market Overview
1.1 Product Overview and Scope of Trastuzumab
1.2 Trastuzumab Segment by Type
1.2.1 Global Trastuzumab Market Value Comparison by Type (2024-2034)
1.2.2 Human Source
1.2.3 Animal Source
1.3 Trastuzumab Segment by Application
1.3.1 Global Trastuzumab Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Global Trastuzumab Market Size Estimates and Forecasts
1.4.1 Global Trastuzumab Revenue 2018-2034
1.4.2 Global Trastuzumab Sales 2018-2034
1.4.3 Global Trastuzumab Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Trastuzumab Market Competition by Manufacturers
2.1 Global Trastuzumab Sales Market Share by Manufacturers (2018-2024)
2.2 Global Trastuzumab Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Trastuzumab Average Price by Manufacturers (2018-2024)
2.4 Global Trastuzumab Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Trastuzumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Trastuzumab, Product Type & Application
2.7 Trastuzumab Market Competitive Situation and Trends
2.7.1 Trastuzumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Trastuzumab Players Market Share by Revenue
2.7.3 Global Trastuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Trastuzumab Retrospective Market Scenario by Region
3.1 Global Trastuzumab Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Trastuzumab Global Trastuzumab Sales by Region: 2018-2034
3.2.1 Global Trastuzumab Sales by Region: 2018-2024
3.2.2 Global Trastuzumab Sales by Region: 2024-2034
3.3 Global Trastuzumab Global Trastuzumab Revenue by Region: 2018-2034
3.3.1 Global Trastuzumab Revenue by Region: 2018-2024
3.3.2 Global Trastuzumab Revenue by Region: 2024-2034
3.4 North America Trastuzumab Market Facts & Figures by Country
3.4.1 North America Trastuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Trastuzumab Sales by Country (2018-2034)
3.4.3 North America Trastuzumab Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Trastuzumab Market Facts & Figures by Country
3.5.1 Europe Trastuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Trastuzumab Sales by Country (2018-2034)
3.5.3 Europe Trastuzumab Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trastuzumab Market Facts & Figures by Country
3.6.1 Asia Pacific Trastuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Trastuzumab Sales by Country (2018-2034)
3.6.3 Asia Pacific Trastuzumab Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Trastuzumab Market Facts & Figures by Country
3.7.1 Latin America Trastuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Trastuzumab Sales by Country (2018-2034)
3.7.3 Latin America Trastuzumab Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Trastuzumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Trastuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Trastuzumab Sales by Country (2018-2034)
3.8.3 Middle East and Africa Trastuzumab Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Trastuzumab Sales by Type (2018-2034)
4.1.1 Global Trastuzumab Sales by Type (2018-2024)
4.1.2 Global Trastuzumab Sales by Type (2024-2034)
4.1.3 Global Trastuzumab Sales Market Share by Type (2018-2034)
4.2 Global Trastuzumab Revenue by Type (2018-2034)
4.2.1 Global Trastuzumab Revenue by Type (2018-2024)
4.2.2 Global Trastuzumab Revenue by Type (2024-2034)
4.2.3 Global Trastuzumab Revenue Market Share by Type (2018-2034)
4.3 Global Trastuzumab Price by Type (2018-2034)
5 Segment by Application
5.1 Global Trastuzumab Sales by Application (2018-2034)
5.1.1 Global Trastuzumab Sales by Application (2018-2024)
5.1.2 Global Trastuzumab Sales by Application (2024-2034)
5.1.3 Global Trastuzumab Sales Market Share by Application (2018-2034)
5.2 Global Trastuzumab Revenue by Application (2018-2034)
5.2.1 Global Trastuzumab Revenue by Application (2018-2024)
5.2.2 Global Trastuzumab Revenue by Application (2024-2034)
5.2.3 Global Trastuzumab Revenue Market Share by Application (2018-2034)
5.3 Global Trastuzumab Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Genentech Inc
6.1.1 Genentech Inc Corporation Information
6.1.2 Genentech Inc Description and Business Overview
6.1.3 Genentech Inc Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Genentech Inc Trastuzumab Product Portfolio
6.1.5 Genentech Inc Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Novartis AG Trastuzumab Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Pfizer Trastuzumab Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Abnova Corporation
6.4.1 Abnova Corporation Corporation Information
6.4.2 Abnova Corporation Description and Business Overview
6.4.3 Abnova Corporation Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Abnova Corporation Trastuzumab Product Portfolio
6.4.5 Abnova Corporation Recent Developments/Updates
6.5 InvivoGen
6.5.1 InvivoGen Corporation Information
6.5.2 InvivoGen Description and Business Overview
6.5.3 InvivoGen Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.5.4 InvivoGen Trastuzumab Product Portfolio
6.5.5 InvivoGen Recent Developments/Updates
6.6 Celltrion
6.6.1 Celltrion Corporation Information
6.6.2 Celltrion Description and Business Overview
6.6.3 Celltrion Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Celltrion Trastuzumab Product Portfolio
6.6.5 Celltrion Recent Developments/Updates
6.7 Biocon Limited
6.6.1 Biocon Limited Corporation Information
6.6.2 Biocon Limited Description and Business Overview
6.6.3 Biocon Limited Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Biocon Limited Trastuzumab Product Portfolio
6.7.5 Biocon Limited Recent Developments/Updates
6.8 Bio-Techne
6.8.1 Bio-Techne Corporation Information
6.8.2 Bio-Techne Description and Business Overview
6.8.3 Bio-Techne Trastuzumab Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bio-Techne Trastuzumab Product Portfolio
6.8.5 Bio-Techne Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trastuzumab Industry Chain Analysis
7.2 Trastuzumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trastuzumab Production Mode & Process
7.4 Trastuzumab Sales and Marketing
7.4.1 Trastuzumab Sales Channels
7.4.2 Trastuzumab Distributors
7.5 Trastuzumab Customers
8 Trastuzumab Market Dynamics
8.1 Trastuzumab Industry Trends
8.2 Trastuzumab Market Drivers
8.3 Trastuzumab Market Challenges
8.4 Trastuzumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Trastuzumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Trastuzumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Trastuzumab Market Competitive Situation by Manufacturers in 2022
Table 4. Global Trastuzumab Sales (MT) of Key Manufacturers (2018-2024)
Table 5. Global Trastuzumab Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Trastuzumab Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Trastuzumab Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Trastuzumab Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Trastuzumab, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Trastuzumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Trastuzumab, Product Type & Application
Table 12. Global Key Manufacturers of Trastuzumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Trastuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Trastuzumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Trastuzumab Sales by Region (2018-2024) & (MT)
Table 18. Global Trastuzumab Sales Market Share by Region (2018-2024)
Table 19. Global Trastuzumab Sales by Region (2024-2034) & (MT)
Table 20. Global Trastuzumab Sales Market Share by Region (2024-2034)
Table 21. Global Trastuzumab Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Trastuzumab Revenue Market Share by Region (2018-2024)
Table 23. Global Trastuzumab Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Trastuzumab Revenue Market Share by Region (2024-2034)
Table 25. North America Trastuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Trastuzumab Sales by Country (2018-2024) & (MT)
Table 27. North America Trastuzumab Sales by Country (2024-2034) & (MT)
Table 28. North America Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Trastuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Trastuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Trastuzumab Sales by Country (2018-2024) & (MT)
Table 32. Europe Trastuzumab Sales by Country (2024-2034) & (MT)
Table 33. Europe Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Trastuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Trastuzumab Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Trastuzumab Sales by Region (2018-2024) & (MT)
Table 37. Asia Pacific Trastuzumab Sales by Region (2024-2034) & (MT)
Table 38. Asia Pacific Trastuzumab Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Trastuzumab Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Trastuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Trastuzumab Sales by Country (2018-2024) & (MT)
Table 42. Latin America Trastuzumab Sales by Country (2024-2034) & (MT)
Table 43. Latin America Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Trastuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Trastuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Trastuzumab Sales by Country (2018-2024) & (MT)
Table 47. Middle East & Africa Trastuzumab Sales by Country (2024-2034) & (MT)
Table 48. Middle East & Africa Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Trastuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Trastuzumab Sales (MT) by Type (2018-2024)
Table 51. Global Trastuzumab Sales (MT) by Type (2024-2034)
Table 52. Global Trastuzumab Sales Market Share by Type (2018-2024)
Table 53. Global Trastuzumab Sales Market Share by Type (2024-2034)
Table 54. Global Trastuzumab Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Trastuzumab Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Trastuzumab Revenue Market Share by Type (2018-2024)
Table 57. Global Trastuzumab Revenue Market Share by Type (2024-2034)
Table 58. Global Trastuzumab Price (USD/MT) by Type (2018-2024)
Table 59. Global Trastuzumab Price (USD/MT) by Type (2024-2034)
Table 60. Global Trastuzumab Sales (MT) by Application (2018-2024)
Table 61. Global Trastuzumab Sales (MT) by Application (2024-2034)
Table 62. Global Trastuzumab Sales Market Share by Application (2018-2024)
Table 63. Global Trastuzumab Sales Market Share by Application (2024-2034)
Table 64. Global Trastuzumab Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Trastuzumab Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Trastuzumab Revenue Market Share by Application (2018-2024)
Table 67. Global Trastuzumab Revenue Market Share by Application (2024-2034)
Table 68. Global Trastuzumab Price (USD/MT) by Application (2018-2024)
Table 69. Global Trastuzumab Price (USD/MT) by Application (2024-2034)
Table 70. Genentech Inc Corporation Information
Table 71. Genentech Inc Description and Business Overview
Table 72. Genentech Inc Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. Genentech Inc Trastuzumab Product
Table 74. Genentech Inc Recent Developments/Updates
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Novartis AG Trastuzumab Product
Table 79. Novartis AG Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Pfizer Trastuzumab Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Abnova Corporation Corporation Information
Table 86. Abnova Corporation Description and Business Overview
Table 87. Abnova Corporation Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Abnova Corporation Trastuzumab Product
Table 89. Abnova Corporation Recent Developments/Updates
Table 90. InvivoGen Corporation Information
Table 91. InvivoGen Description and Business Overview
Table 92. InvivoGen Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. InvivoGen Trastuzumab Product
Table 94. InvivoGen Recent Developments/Updates
Table 95. Celltrion Corporation Information
Table 96. Celltrion Description and Business Overview
Table 97. Celltrion Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Celltrion Trastuzumab Product
Table 99. Celltrion Recent Developments/Updates
Table 100. Biocon Limited Corporation Information
Table 101. Biocon Limited Description and Business Overview
Table 102. Biocon Limited Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Biocon Limited Trastuzumab Product
Table 104. Biocon Limited Recent Developments/Updates
Table 105. Bio-Techne Corporation Information
Table 106. Bio-Techne Description and Business Overview
Table 107. Bio-Techne Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. Bio-Techne Trastuzumab Product
Table 109. Bio-Techne Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Trastuzumab Distributors List
Table 113. Trastuzumab Customers List
Table 114. Trastuzumab Market Trends
Table 115. Trastuzumab Market Drivers
Table 116. Trastuzumab Market Challenges
Table 117. Trastuzumab Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Trastuzumab
Figure 2. Global Trastuzumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Trastuzumab Market Share by Type in 2022 & 2034
Figure 4. Human Source Product Picture
Figure 5. Animal Source Product Picture
Figure 6. Global Trastuzumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Trastuzumab Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Medical Center
Figure 10. Global Trastuzumab Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 11. Global Trastuzumab Market Size (2018-2034) & (US$ Million)
Figure 12. Global Trastuzumab Sales (2018-2034) & (MT)
Figure 13. Global Trastuzumab Average Price (USD/MT) & (2018-2034)
Figure 14. Trastuzumab Report Years Considered
Figure 15. Trastuzumab Sales Share by Manufacturers in 2022
Figure 16. Global Trastuzumab Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Trastuzumab Players: Market Share by Revenue in 2022
Figure 18. Trastuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Trastuzumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 20. North America Trastuzumab Sales Market Share by Country (2018-2034)
Figure 21. North America Trastuzumab Revenue Market Share by Country (2018-2034)
Figure 22. U.S. Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Trastuzumab Sales Market Share by Country (2018-2034)
Figure 25. Europe Trastuzumab Revenue Market Share by Country (2018-2034)
Figure 26. Germany Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Trastuzumab Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Trastuzumab Revenue Market Share by Region (2018-2034)
Figure 33. China Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Trastuzumab Sales Market Share by Country (2018-2034)
Figure 44. Latin America Trastuzumab Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Trastuzumab Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Trastuzumab Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. U.A.E Trastuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Trastuzumab by Type (2018-2034)
Figure 54. Global Revenue Market Share of Trastuzumab by Type (2018-2034)
Figure 55. Global Trastuzumab Price (USD/MT) by Type (2018-2034)
Figure 56. Global Sales Market Share of Trastuzumab by Application (2018-2034)
Figure 57. Global Revenue Market Share of Trastuzumab by Application (2018-2034)
Figure 58. Global Trastuzumab Price (USD/MT) by Application (2018-2034)
Figure 59. Trastuzumab Value Chain
Figure 60. Trastuzumab Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed